Third Party Activities. Have you performed CMO activities for third parties using the PER.C6® cell line or worked with the PER.C6® cell line in collaborations programs with third parties? If yes, please state the name of the company/companies and a short description of the project(s). • Has a CMO performed any activities with the PER.C6® cell line? If yes, please state the name of the company/companies and a short description of the project(s). Commercial License Agreement PER.C6® Crucell Holland – Vascular Biogenics
Appears in 2 contracts
Sources: Commercial Gene Therapy License Agreement (Vascular Biogenics Ltd.), Commercial Gene Therapy License Agreement (Vascular Biogenics Ltd.)